메뉴 건너뛰기




Volumn 19, Issue 44, 2013, Pages 8108-8113

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells

Author keywords

Colon cancer; Gene therapy; Growth hormone receptor; Signaling pathway; Small interfering RNAs

Indexed keywords

FLUOROURACIL; GROWTH HORMONE RECEPTOR; SMALL INTERFERING RNA;

EID: 84888581190     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i44.8108     Document Type: Article
Times cited : (5)

References (25)
  • 1
    • 0034025706 scopus 로고    scopus 로고
    • Growth hormone and colorectal carcinoma: Localization of receptors
    • [PMID: 10757060]
    • Lincoln DT, Kaiser HE, Raju GP, Waters MJ. Growth hormone and colorectal carcinoma: localization of receptors. In Vivo 2000; 14: 41-49 [PMID: 10757060]
    • (2000) In Vivo , vol.14 , pp. 41-49
    • Lincoln, D.T.1    Kaiser, H.E.2    Raju, G.P.3    Waters, M.J.4
  • 3
    • 0037183320 scopus 로고    scopus 로고
    • Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: A cohort study
    • [PMID: 12147369 DOI: 10.1016/S0140-6736(02)09519-3]
    • Swerdlow AJ, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 2002; 360: 273-277 [PMID: 12147369 DOI: 10.1016/S0140-6736(02)09519-3]
    • (2002) Lancet , vol.360 , pp. 273-277
    • Swerdlow, A.J.1    Higgins, C.D.2    Adlard, P.3    Preece, M.A.4
  • 4
    • 0038359743 scopus 로고    scopus 로고
    • Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform
    • [PMID: 12679461 DOI: 10.1210/ jc.2002-021667]
    • Pantel J, Grulich-Henn J, Bettendorf M, Strasburger CJ, Heinrich U, Amselem S. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform. J Clin Endocrinol Metab 2003; 88: 1705-1710 [PMID: 12679461 DOI: 10.1210/ jc.2002-021667]
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 1705-1710
    • Pantel, J.1    Grulich-Henn, J.2    Bettendorf, M.3    Strasburger, C.J.4    Heinrich, U.5    Amselem, S.6
  • 5
    • 0037014743 scopus 로고    scopus 로고
    • Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer
    • [PMID: 12096082 DOI: 10.1093/jnci/94.13.972]
    • Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002; 94: 972-980 [PMID: 12096082 DOI: 10.1093/jnci/94.13.972]
    • (2002) J Natl Cancer Inst , vol.94 , pp. 972-980
    • Sandhu, M.S.1    Dunger, D.B.2    Giovannucci, E.L.3
  • 6
    • 0037398468 scopus 로고    scopus 로고
    • Degree of fatness after treatment of malignant lymphoma in childhood
    • [PMID: 12555252 DOI: 10.1002/mpo.10260]
    • Nysom K, Holm K, Michaelsen KF, Hertz H, Müller J, Mølgaard C. Degree of fatness after treatment of malignant lymphoma in childhood. Med Pediatr Oncol 2003; 40: 239-243 [PMID: 12555252 DOI: 10.1002/mpo.10260]
    • (2003) Med Pediatr Oncol , vol.40 , pp. 239-243
    • Nysom, K.1    Holm, K.2    Michaelsen, K.F.3    Hertz, H.4    Müller, J.5    Mølgaard, C.6
  • 7
    • 0034657348 scopus 로고    scopus 로고
    • The role of STAT proteins in growth hormone signaling
    • [PMID: 10851057 DOI: 10.1038/sj.onc.1203526]
    • Herrington J, Smit LS, Schwartz J, Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene 2000; 19: 2585-2597 [PMID: 10851057 DOI: 10.1038/sj.onc.1203526]
    • (2000) Oncogene , vol.19 , pp. 2585-2597
    • Herrington, J.1    Smit, L.S.2    Schwartz, J.3    Carter-Su, C.4
  • 9
    • 33847376775 scopus 로고    scopus 로고
    • Growth hormone treatment and cancer risk
    • [PMID: 17336744 DOI: 10.1016/j.ecl.2006.11.007]
    • Banerjee I, Clayton PE. Growth hormone treatment and cancer risk. Endocrinol Metab Clin North Am 2007; 36: 247-263 [PMID: 17336744 DOI: 10.1016/j.ecl.2006.11.007]
    • (2007) Endocrinol Metab Clin North Am , vol.36 , pp. 247-263
    • Banerjee, I.1    Clayton, P.E.2
  • 10
    • 0037169829 scopus 로고    scopus 로고
    • Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: New insights into signaling pathways
    • [PMID: 11911939 DOI: 10.1016/S0303-7207(02)00014-X]
    • Jeay S, Sonenshein GE, Postel-Vinay MC, Kelly PA, Baixeras E. Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways. Mol Cell Endocrinol 2002; 188: 1-7 [PMID: 11911939 DOI: 10.1016/S0303-7207(02)00014-X]
    • (2002) Mol Cell Endocrinol , vol.188 , pp. 1-7
    • Jeay, S.1    Sonenshein, G.E.2    Postel-Vinay, M.C.3    Kelly, P.A.4    Baixeras, E.5
  • 11
    • 33746906218 scopus 로고    scopus 로고
    • The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth
    • [PMID: 16541323 DOI: 10.1007/s10549-006-9168-1]
    • Divisova J, Kuiatse I, Lazard Z, Weiss H, Vreeland F, Hadsell DL, Schiff R, Osborne CK, Lee AV. The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth. Breast Cancer Res Treat 2006; 98: 315-327 [PMID: 16541323 DOI: 10.1007/s10549-006-9168-1]
    • (2006) Breast Cancer Res Treat , vol.98 , pp. 315-327
    • Divisova, J.1    Kuiatse, I.2    Lazard, Z.3    Weiss, H.4    Vreeland, F.5    Hadsell, D.L.6    Schiff, R.7    Osborne, C.K.8    Lee, A.V.9
  • 12
    • 0036725771 scopus 로고    scopus 로고
    • Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment?
    • [PMID: 12242146 DOI: 10.1016/S1535-6108(02)00129-0]
    • Borkhardt A. Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment? Cancer Cell 2002; 2: 167-168 [PMID: 12242146 DOI: 10.1016/S1535-6108(02)00129-0]
    • (2002) Cancer Cell , vol.2 , pp. 167-168
    • Borkhardt, A.1
  • 13
    • 4243754537 scopus 로고    scopus 로고
    • Confirming specificity of RNAi in mammalian cells
    • [PMID: 12198178 DOI: 10.1126/scisignal.1472002pl13]
    • Lassus P, Rodriguez J, Lazebnik Y. Confirming specificity of RNAi in mammalian cells. Sci STKE 2002; 2002: pl13 [PMID: 12198178 DOI: 10.1126/scisignal.1472002pl13]
    • (2002) Sci STKE , vol.2002 , pp. 13
    • Lassus, P.1    Rodriguez, J.2    Lazebnik, Y.3
  • 14
  • 16
    • 34250902061 scopus 로고    scopus 로고
    • Gene expression profiling in sarcomas
    • [PMID: 17555981 DOI: 10.1016/ j.critrevonc.2007.04.001]
    • Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD. Gene expression profiling in sarcomas. Crit Rev Oncol Hematol 2007; 63: 111-124 [PMID: 17555981 DOI: 10.1016/ j.critrevonc.2007.04.001]
    • (2007) Crit Rev Oncol Hematol , vol.63 , pp. 111-124
    • Tschoep, K.1    Kohlmann, A.2    Schlemmer, M.3    Haferlach, T.4    Issels, R.D.5
  • 17
    • 0037308230 scopus 로고    scopus 로고
    • Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: A positive study
    • [PMID: 12557135 DOI: 10.1053/gast.2003.50057]
    • Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 2003; 124: 293-302 [PMID: 12557135 DOI: 10.1053/gast.2003.50057]
    • (2003) Gastroenterology , vol.124 , pp. 293-302
    • Seguy, D.1    Vahedi, K.2    Kapel, N.3    Souberbielle, J.C.4    Messing, B.5
  • 18
    • 33847392443 scopus 로고    scopus 로고
    • Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: Implications for cancer therapy
    • [PMID: 17289896 DOI: 10.1158/1078-0432.CCR-06-1910]
    • Yin D, Vreeland F, Schaaf LJ, Millham R, Duncan BA, Sharma A. Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy. Clin Cancer Res 2007; 13: 1000-1009 [PMID: 17289896 DOI: 10.1158/1078-0432.CCR-06-1910]
    • (2007) Clin Cancer Res , vol.13 , pp. 1000-1009
    • Yin, D.1    Vreeland, F.2    Schaaf, L.J.3    Millham, R.4    Duncan, B.A.5    Sharma, A.6
  • 19
    • 33645022208 scopus 로고    scopus 로고
    • Does growth hormone cause cancer?
    • [PMID: 16430706 DOI: 10.1111/j.1365-2265.2005.02404.x]
    • Jenkins PJ, Mukherjee A, Shalet SM. Does growth hormone cause cancer? Clin Endocrinol (Oxf) 2006; 64: 115-121 [PMID: 16430706 DOI: 10.1111/j.1365-2265.2005.02404.x]
    • (2006) Clin Endocrinol (Oxf) , vol.64 , pp. 115-121
    • Jenkins, P.J.1    Mukherjee, A.2    Shalet, S.M.3
  • 20
    • 0034773409 scopus 로고    scopus 로고
    • Expression of the insulin-like growth factors (IGFs) and the IGFbinding proteins (IGFBPs) in human gastric cancer cells
    • [PMID: 11677116 DOI: 10.1016/ S0959-8049(01)00269-6]
    • Yi HK, Hwang PH, Yang DH, Kang CW, Lee DY. Expression of the insulin-like growth factors (IGFs) and the IGFbinding proteins (IGFBPs) in human gastric cancer cells. Eur J Cancer 2001; 37: 2257-2263 [PMID: 11677116 DOI: 10.1016/ S0959-8049(01)00269-6]
    • (2001) Eur J Cancer , vol.37 , pp. 2257-2263
    • Yi, H.K.1    Hwang, P.H.2    Yang, D.H.3    Kang, C.W.4    Lee, D.Y.5
  • 21
    • 33745324588 scopus 로고    scopus 로고
    • Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy
    • [PMID: 16516462 DOI: 10.1016/j.ejca.2005.12.012]
    • Wu X, Wan M, Li G, Xu Z, Chen C, Liu F, Li J. Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy. Eur J Cancer 2006; 42: 888-894 [PMID: 16516462 DOI: 10.1016/j.ejca.2005.12.012]
    • (2006) Eur J Cancer , vol.42 , pp. 888-894
    • Wu, X.1    Wan, M.2    Li, G.3    Xu, Z.4    Chen, C.5    Liu, F.6    Li, J.7
  • 24
    • 34250379038 scopus 로고    scopus 로고
    • RNAi gene silencing using cerasome as a viral-size siRNA-carrier free from fusion and cross-linking
    • [PMID: 17502138 DOI: 10.1016/ j.bmcl.2007.04]
    • Matsui K, Sasaki Y, Komatsu T, Mukai M, Kikuchi J, Aoyama Y. RNAi gene silencing using cerasome as a viral-size siRNA-carrier free from fusion and cross-linking. Bioorg Med Chem Lett 2007; 17: 3935-3938 [PMID: 17502138 DOI: 10.1016/ j.bmcl.2007.04]
    • (2007) Bioorg Med Chem Lett , vol.17 , pp. 3935-3938
    • Matsui, K.1    Sasaki, Y.2    Komatsu, T.3    Mukai, M.4    Kikuchi, J.5    Aoyama, Y.6
  • 25
    • 0038047685 scopus 로고    scopus 로고
    • AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t (8; 21)-positive leukemic cells
    • [PMID: 12480707 DOI: 10.1182/ blood-2002-05-1589]
    • Heidenreich O, Krauter J, Riehle H, Hadwiger P, John M, Heil G, Vornlocher HP, Nordheim A. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t (8; 21)-positive leukemic cells. Blood 2003; 101: 3157-3163 [PMID: 12480707 DOI: 10.1182/ blood-2002-05-1589]
    • (2003) Blood , vol.101 , pp. 3157-3163
    • Heidenreich, O.1    Krauter, J.2    Riehle, H.3    Hadwiger, P.4    John, M.5    Heil, G.6    Vornlocher, H.P.7    Nordheim, A.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.